NFL and UFC athletes try ibogaine to treat brain injury

Ibogaine is gaining attention among NFL and UFC athletes as a potential treatment for traumatic brain injury, anxiety, and depression, despite being a Schedule 1 drug in the United States with no accepted medical uses. Athletes cited in the report describe personal outcomes they credit to ibogaine, including reduced depression and anxiety and relief from suicidal ideation after traveling for treatment. The article also references veteran-focused interest in the compound because head trauma and PTSD are common in that community. The story points to a Stanford-affiliated observational study of special forces veterans reporting large average symptom reductions for PTSD, depression, and anxiety, alongside improvements in concentration and memory. It also lays out regulatory barriers for federal approval, discusses how supervised programs may expand through state exemptions, and summarizes proposed mechanisms such as increases in neurotrophic factors that could support brain healing.